ModerateSynergy
Chlorthalidone commonly lowers serum potassium through renal potassium wasting. Potassium supplementation can be clinically useful when levels are low, but excessive supplementation can be risky in kidney disease or when combined with ACE inhibitors, ARBs, or potassium-sparing diuretics. Low potassium can cause weakness, cramps, palpitations, and arrhythmias.
Recommendation: Do not self-treat chlorthalidone-related low potassium with high-dose potassium unless your prescriber confirms the dose. Check potassium after starting chlorthalidone, after dose changes, and periodically during chronic therapy.
ModerateSynergy
Long-term chlorthalidone therapy can lower magnesium as well as potassium. Magnesium glycinate may help replace magnesium when levels are low or when low potassium is difficult to correct. Risk is higher with prolonged therapy, older age, low dietary magnesium intake, or high diuretic doses.
Recommendation: Ask for magnesium and potassium checks if you take chlorthalidone chronically. Magnesium glycinate can be reasonable for repletion, but avoid high doses without monitoring if you have kidney disease.
ModerateSynergy
Chlorthalidone can cause magnesium depletion during long-term treatment. Magnesium citrate may help replenish magnesium, particularly when potassium is also low or difficult to normalize. The combination is usually supportive, but magnesium dosing still matters in kidney disease.
Recommendation: If you take chlorthalidone, ask whether magnesium and potassium should be checked periodically. Use magnesium citrate as monitored repletion rather than escalating the dose on your own.
ModerateSynergy
Chlorthalidone has documented potential to lower magnesium during chronic treatment. Magnesium malate is a magnesium-containing supplement that can support replacement when depletion is present. This is most important when low magnesium accompanies low potassium, muscle symptoms, or arrhythmia risk.
Recommendation: Ask your prescriber about checking magnesium if you use chlorthalidone long term. Use magnesium malate at a consistent replacement dose and avoid high-dose use without kidney-function monitoring.
ModerateSynergy
Chlorthalidone can lower magnesium and potassium during long-term use. Magnesium taurate may help replenish magnesium stores if supplementation is needed. Patients with kidney disease should avoid high magnesium doses unless labs are being followed.
Recommendation: If you take chlorthalidone chronically, check whether magnesium monitoring is appropriate along with potassium monitoring. Use magnesium taurate cautiously and consistently, especially if kidney function is reduced.
ModerateCaution
Chlorthalidone is thiazide-like and reduces urinary calcium loss, which can raise serum calcium. High-dose calcium supplements can add to that effect and increase hypercalcemia risk, especially with dehydration, kidney disease, hyperparathyroidism, or heavy calcium antacid use. Symptoms may include nausea, constipation, thirst, confusion, weakness, or kidney injury.
Recommendation: Avoid high-dose calcium while taking chlorthalidone unless your prescriber recommends and monitors it. If you need daily calcium, keep the dose within your target intake and ask whether serum calcium should be checked.
ModerateCaution
Chlorthalidone can increase serum calcium by lowering urinary calcium excretion, while Vitamin D3 increases intestinal calcium absorption. Usual Vitamin D3 replacement is often tolerated, but high-dose supplementation or combined calcium use can increase hypercalcemia risk. This matters most in kidney disease, hyperparathyroidism, granulomatous disease, or dehydration.
Recommendation: Use Vitamin D3 with a monitoring plan if you take chlorthalidone and need high-dose therapy. Ask about checking serum calcium after starting Vitamin D3, increasing the dose, or adding calcium.
ModerateCaution
Chlorthalidone reduces urinary calcium excretion, and Vitamin D2 can increase calcium absorption after metabolic activation. High-dose Vitamin D2 can therefore add to chlorthalidone's calcium-retaining effect. The concern is greatest when calcium supplements are also used or when kidney disease, hyperparathyroidism, granulomatous disease, or dehydration is present.
Recommendation: Avoid high-dose Vitamin D2 with chlorthalidone unless your clinician is tracking calcium. If Vitamin D2 is prescribed, ask when to recheck serum calcium and whether your calcium supplement dose should be adjusted.
ModerateCaution
Chlorthalidone has a long duration of action and can cause volume depletion, low sodium, and low potassium. Alcohol can worsen orthostatic hypotension and dehydration, increasing the risk of dizziness, falls, or fainting. Older adults and people who are ill, overheated, or on multiple blood-pressure medicines are at higher risk.
Recommendation: Limit alcohol while taking chlorthalidone, particularly during the first weeks of therapy or after dose changes. Maintain appropriate hydration, stand slowly, and contact your prescriber if you have recurrent dizziness, fainting, or weakness.
ModerateCaution
L-Arginine can lower blood pressure, and chlorthalidone is a long-acting antihypertensive diuretic. Combining them can produce additive blood-pressure lowering, especially in people already controlled on chlorthalidone or prone to dehydration. Symptoms can include dizziness, weakness, headache, or fainting.
Recommendation: Start L-Arginine cautiously if you take chlorthalidone and monitor home blood pressure for 1-2 weeks. Stop or lower the supplement and contact your prescriber if you develop lightheadedness, fainting, or consistently low readings.
ModerateCaution
L-Citrulline can modestly lower blood pressure through the arginine-nitric oxide pathway. Chlorthalidone has sustained antihypertensive and diuretic effects, so adding L-Citrulline can increase the chance of symptomatic low blood pressure. Dehydration, low sodium, older age, and multi-drug blood-pressure therapy increase risk.
Recommendation: If you use L-Citrulline with chlorthalidone, begin with a low dose and check blood pressure at home. Reduce or stop it if you develop dizziness, fainting, or readings below your usual range, and discuss persistent symptoms with your prescriber.
NutriStack